DEXCOM INC — Director's Dealing 2020

Oct 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-10-11

Reporting Person: Malady Kyle (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-11	Common Stock	A	1272	$0.001	Acquired	1272	Direct

Footnotes

F1: Represents a grant of restricted stock units subject to vest one-third per year on the anniversary of the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.